Literature DB >> 17283217

UK GPs' and practice nurses' views of continuity of care for patients with type 2 diabetes.

Mohammed H Alazri1, Philip Heywood, Richard D Neal, Brenda Leese.   

Abstract

BACKGROUND: Continuity of care is widely regarded as a core value of primary care. Type 2 diabetes is a common chronic disease with major health, social and economic impacts. Primary health care professionals in many countries are involved in the management of patients with type 2 diabetes, but their perspectives on continuity remain neglected in research.
OBJECTIVE: To explore UK GPs' and nurses' experiences of continuity of care for patients with type 2 diabetes in primary care settings.
METHODS: Semi-structured individual interviews were conducted with 16 GPs and 18 practice nurses who manage patients with type 2 diabetes recruited from 20 practices with various organizational structures in Leeds, UK.
RESULTS: Three types of continuities were identified: relational continuity from the same health care professional, team continuity from a group of health care professionals and cross-boundary continuity across primary-secondary care settings. Relational continuity was influenced by the quality of the patient-health care professional relationship, policy of the National Health Service (NHS) in the UK (new General Medical Services contract), walk-in centres, the behaviour of receptionists and the structure and systems of the practice. Team and cross-boundary continuities were influenced by the relationship between team members and by effective communication. Relational continuity contributed to more 'personal care', but the usual health care professional might know less about diabetes. Team continuity was important in providing 'physical care', but patients could be confused by conflicting advice from different professionals. Cross-boundary continuity helps to provide 'expert advice', but is dependent upon effective communication.
CONCLUSION: GPs and practice nurses dealing with patients with type 2 diabetes identified three types of continuities, each influenced by several factors. Relational continuity deals better with psychosocial care while team continuity promotes better physical care; therefore, imposing one type of continuity may inhibit good diabetic care. Cross-boundary continuity between primary and secondary care is fundamental to contemporary diabetic services and ways should be found to achieve more effective communication.

Entities:  

Mesh:

Year:  2007        PMID: 17283217     DOI: 10.1093/fampra/cmm003

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  6 in total

1.  Continuity of care and quality of care - inseparable twin.

Authors:  Mohammed Al-Azri
Journal:  Oman Med J       Date:  2008-07

2.  Continuity of Care: Literature review and implications.

Authors:  Mohammed Alazri; Philip Heywood; Richard D Neal; Brenda Leese
Journal:  Sultan Qaboos Univ Med J       Date:  2007-12

Review 3.  Continuity of Care in Chronic Diseases: A Concept Analysis by Literature Review.

Authors:  Jingjing Hu; Yuexia Wang; Xiaoxi Li
Journal:  J Korean Acad Nurs       Date:  2020-08       Impact factor: 0.984

4.  Prioritizing Community-Based Intervention Programs for Improving Treatment Compliance of Patients with Chronic Diseases: Applying an Analytic Hierarchy Process.

Authors:  Do Hwa Byun; Rho Soon Chang; Myung-Bae Park; Hyo-Rim Son; Chun-Bae Kim
Journal:  Int J Environ Res Public Health       Date:  2021-01-08       Impact factor: 3.390

5.  Analysis of Continuity of Care and Its Related Factors in Diabetic Patients: A Cross-Sectional Study.

Authors:  Ji Yeh Shin; Ha Jin Kim; BeLong Cho; Yun Jun Yang; Jae Moon Yun
Journal:  Korean J Fam Med       Date:  2022-07-19

6.  Heart failure patients' experiences with continuity of care and its relation to medication adherence: a cross-sectional study.

Authors:  Annemarie A Uijen; Marije Bosch; Wil J H M van den Bosch; Hans Bor; Michel Wensing; Henk J Schers
Journal:  BMC Fam Pract       Date:  2012-08-20       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.